The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis - PubMed (original) (raw)
The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
Mustafa S Ascha et al. Hepatology. 2010 Jun.
Abstract
Nonalcoholic steatohepatitis (NASH) is a well-recognized cause of cirrhosis and has been increasingly associated with the development of hepatocellular carcinoma (HCC). The aims of this study were to (1) estimate the incidence of HCC in patients with NASH-related cirrhosis, (2) compare incidence in NASH-related cirrhosis with hepatitis C virus (HCV)-related cirrhosis, and (3) identify risk factors of HCC in patients with NASH-related cirrhosis compared with HCV-related cirrhosis. Adult patients with cirrhosis secondary to chronic HCV (n = 315) or NASH (n = 195) were evaluated at our hepatobiliary clinic between 2003 and 2007. To assess for HCC development, all patients were monitored using serial abdominal computed tomography and serum alpha-fetoprotein every 6 months. Kaplan-Meier analysis was performed to estimate the cumulative incidence of HCC. Descriptive statistics were computed for all factors. Univariate and multivariate Cox regression analysis were used to assess associations between HCC and factors of interest. The median follow-up was 3.2 years (25th percentile [P25], 75th percentile [P75]: 1.7, 5.7) during which 25/195 (12.8%) of NASH-cirrhotic and 64/315 (20.3 %) of HCV-cirrhotic patients developed HCC (P = 0.03). Yearly cumulative incidence of HCC was found to be 2.6% in patients with NASH-cirrhosis, compared with 4.0% in patients with HCV cirrhosis (P = 0.09). Multivariate regression analysis revealed that older age (P = 0.006) and alcohol consumption (P = 0.002) were independent variables associated with development of HCC in patients with NASH-cirrhosis. Compared with nondrinkers, patients who reported any regular alcohol consumption were at greater risk for HCC development (hazard ratio: 3.6; P25, P75: 1.5, 8.3).
Conclusion: Patients with NASH cirrhosis have a greatly increased risk of liver cancer. Alcohol consumption, a modifiable risk factor, appears to be the most significant factor associated with risk of HCC development in our study population.
Comment in
- Possible role of adipocytokines in the development of nonalcoholic steatohepatitis-related hepatocellular carcinoma.
Beyazit Y, Kekilli M, Purnak T, Kurt M. Beyazit Y, et al. Hepatology. 2010 Sep;52(3):1172. doi: 10.1002/hep.23701. Hepatology. 2010. PMID: 20683933 No abstract available.
Similar articles
- Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R. Chiaramonte M, et al. Cancer. 1999 May 15;85(10):2132-7. Cancer. 1999. PMID: 10326690 - Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease.
Reddy SK, Steel JL, Chen HW, DeMateo DJ, Cardinal J, Behari J, Humar A, Marsh JW, Geller DA, Tsung A. Reddy SK, et al. Hepatology. 2012 Jun;55(6):1809-19. doi: 10.1002/hep.25536. Epub 2012 Apr 23. Hepatology. 2012. PMID: 22183968 - Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
Pekow JR, Bhan AK, Zheng H, Chung RT. Pekow JR, et al. Cancer. 2007 Jun 15;109(12):2490-6. doi: 10.1002/cncr.22701. Cancer. 2007. PMID: 17487861 - Etiological factor of hepatocellular carcinoma in Italy.
Stroffolini T. Stroffolini T. Minerva Gastroenterol Dietol. 2005 Mar;51(1):1-5. Minerva Gastroenterol Dietol. 2005. PMID: 15756142 Review. - Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS. Chen DS. Princess Takamatsu Symp. 1995;25:27-32. Princess Takamatsu Symp. 1995. PMID: 8875606 Review.
Cited by
- Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis via AMPK and mTOR regulation.
Fernández-Ramos D, Lopitz-Otsoa F, Delacruz-Villar L, Bilbao J, Pagano M, Mosca L, Bizkarguenaga M, Serrano-Macia M, Azkargorta M, Iruarrizaga-Lejarreta M, Sot J, Tsvirkun D, van Liempd SM, Goni FM, Alonso C, Martínez-Chantar ML, Elortza F, Hayardeny L, Lu SC, Mato JM. Fernández-Ramos D, et al. World J Gastroenterol. 2020 Sep 14;26(34):5101-5117. doi: 10.3748/wjg.v26.i34.5101. World J Gastroenterol. 2020. PMID: 32982112 Free PMC article. - Decreased FXR Agonism in the Bile Acid Pool Is Associated with Impaired FXR Signaling in a Pig Model of Pediatric NAFLD.
Maj MA, Burrin DG, Manjarín R. Maj MA, et al. Biomedicines. 2023 Dec 13;11(12):3303. doi: 10.3390/biomedicines11123303. Biomedicines. 2023. PMID: 38137523 Free PMC article. - Association between PNPLA3 (rs738409), LYPLAL1 (rs12137855), PPP1R3B (rs4240624), GCKR (rs780094), and elevated transaminase levels in overweight/obese Mexican adults.
Flores YN, Velázquez-Cruz R, Ramírez P, Bañuelos M, Zhang ZF, Yee HF Jr, Chang SC, Canizales-Quinteros S, Quiterio M, Cabrera-Alvarez G, Patiño N, Salmerón J. Flores YN, et al. Mol Biol Rep. 2016 Dec;43(12):1359-1369. doi: 10.1007/s11033-016-4058-z. Epub 2016 Oct 17. Mol Biol Rep. 2016. PMID: 27752939 Free PMC article. - Natural History of NAFLD.
Pais R, Maurel T. Pais R, et al. J Clin Med. 2021 Mar 10;10(6):1161. doi: 10.3390/jcm10061161. J Clin Med. 2021. PMID: 33802047 Free PMC article. Review. - Fibrosis-dependent mechanisms of hepatocarcinogenesis.
Zhang DY, Friedman SL. Zhang DY, et al. Hepatology. 2012 Aug;56(2):769-75. doi: 10.1002/hep.25670. Epub 2012 Jun 29. Hepatology. 2012. PMID: 22378017 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials